Cupric Sulfate

Sold as Cupric Sulfate. Every FDA application for this active ingredient: 1 branded and 2 generic.

As of Nov 15, 2026, FDA lists 3 applications for Cupric Sulfate (sold as Cupric Sulfate), first approved May 5, 1987, with 0 new uses approved and 0 published complete response letters.

First approved: May 5, 1987
Applications: 3
New uses approved: 0
Complete response letters: 0

Clinical Trials

1 open or ongoing study names this ingredient as an intervention, including as a comparator; newest first. See all

Study	Phase	Status	Posted
Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in EthiopiaBirth Weight · London School of Hygiene and Tropical Medicine	—	Recruiting	Feb 1, 2023

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history


May 5, 1987	Cupric SulfateNDA 19350 · New formulation or manufacturer	Abraxis Pharm	2	Discontinued
Dec 16, 2022	Cupric SulfateANDA 216324	Am Regent	1	Marketed
Aug 19, 2024	Cupric SulfateANDA 218745	Apotex Corp	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA